DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Xeloda (Capecitabine) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (76)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Xeloda (Capecitabine) disability. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 76   Next >>

Possible Xeloda side effects in female

Reported by a consumer/non-health professional from Mexico on 2012-08-27

Patient: female, weighing 43.0 kg (94.6 pounds)

Reactions: Thrombosis, Vomiting, Monoplegia, Nausea, Diarrhoea, Oedema Peripheral, Headache

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in

Reported by a consumer/non-health professional from United States on 2012-08-25

Patient:

Reactions: Death, Ill-Defined Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Tarceva
    Indication: Brain Neoplasm Malignant

Tarceva

Xeloda
    Indication: Brain Neoplasm Malignant

Xeloda



Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-08-24

Patient: female, weighing 49.0 kg (107.8 pounds)

Reactions: Stomatitis, Disseminated Intravascular Coagulation, Pancytopenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Ketoacidosis, Diarrhoea, Cerebral Infarction, Altered State of Consciousness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Tamoxifen Citrate



Possible Xeloda side effects in female

Reported by a physician from Australia on 2012-08-24

Patient: female, weighing 109.0 kg (239.8 pounds)

Reactions: Nausea, Urinary Tract Infection, Atrial Fibrillation, Pyrexia, Anastomotic Leak, Hypokalaemia, Diarrhoea, Ventricular Tachycardia, Dehydration, Hypoalbuminaemia, Decreased Appetite, Anastomotic Fistula

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Oxaliplatin
    Dosage: last dose prior to sae on 21mar 2011 (50 mg/m2 on day1, 8, 15, 21 and 29).
    Indication: Rectal Cancer
    Start date: 2011-02-21
    End date: 2011-08-10

Xeloda
    Dosage: last date prior to sae: 26 march 2011 250 mg. (825 mg/m2 bid d1-33 w/o weekends and optional boost),
    Administration route: Oral
    Indication: Rectal Cancer
    Start date: 2011-02-21
    End date: 2011-08-10

Other drugs received by patient: Salmeterol; Colecalciferol; Potassium; Aspirin; Fluticasone Propionate; Pantoprazole; Prednisolone; Methotrexate; Acetaminophen; Metoprolol Tartrate; Diclofenac Sodium; Ferrous Sulfate TAB; Olmesartan Medoxomil; Enoxaparin; Folic Acid; Magnesium; Verapamil; Metoclopramide



Possible Xeloda side effects in male

Reported by a physician from Japan on 2012-08-20

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Anorectal Disorder, Quadriplegia, Bladder Disorder, Multiple Sclerosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Oxaliplatin



Possible Xeloda side effects in 83 year old male

Reported by a pharmacist from Canada on 2012-08-16

Patient: 83 year old male, weighing 60.8 kg (133.8 pounds)

Reactions: Stomatitis, Skin Exfoliation, Pancytopenia, Pyrexia, Erythema, Eating Disorder, Epidermolysis, Burning Sensation, Dyspepsia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Metoclopramide; Senna-Mint WAF; Flomax (Canada); Loperamide; Ciprofloxacin HCL; Magic Mouth Wash (Ingredients Unk)



Possible Xeloda side effects in 68 year old female

Reported by a physician from Japan on 2012-07-19

Patient: 68 year old female

Reactions: Skin Disorder, Palmar-Plantar Erythrodysaesthesia Syndrome

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Tykerb
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Breast Cancer Metastatic

Xeloda
    Administration route: Oral
    Start date: 2011-04-01
    End date: 2011-06-24

Xeloda
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-09-24
    End date: 2011-03-29

Tykerb
    Dosage: amount of 80%
    Administration route: Oral

Tykerb
    Dosage: dosage is uncertain.
    Administration route: Oral

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral



Possible Xeloda side effects in 37 year old female

Reported by a physician from Russian Federation on 2012-07-13

Patient: 37 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Weight Increased, Disease Progression

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in male

Reported by a pharmacist from Japan on 2012-06-29

Patient: male, weighing 49.0 kg (107.8 pounds)

Reactions: Disseminated Intravascular Coagulation, Pancytopenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Ketoacidosis, Cerebral Infarction, Diarrhoea, Oral Mucosa Erosion, Altered State of Consciousness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Tamoxifen Citrate



Possible Xeloda side effects in female

Reported by a physician from Australia on 2012-06-26

Patient: female, weighing 109.0 kg (239.8 pounds)

Reactions: Nausea, Urinary Tract Infection, Atrial Fibrillation, Pyrexia, Anastomotic Leak, Hypokalaemia, Diarrhoea, Dehydration, Ventricular Tachycardia, Hypoalbuminaemia, Decreased Appetite, Anastomotic Fistula

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Xeloda
    Dosage: last date prior to sae: 26 march 2011 250 mg. (825 mg/m2 bid d1-33 w/o weekends and optional boost),
    Administration route: Oral
    Indication: Rectal Cancer
    Start date: 2011-02-21
    End date: 2011-08-10

Oxaliplatin
    Dosage: last dose prior to sae on 21mar 2011 (50 mg/m2 on day1, 8, 15, 21 and 29).
    Indication: Rectal Cancer
    Start date: 2011-02-21
    End date: 2011-08-10

Other drugs received by patient: Olmesartan Medoxomil; Salmeterol; Prednisolone; Folic Acid; Aspirin; Ferrous Sulfate TAB; Fluticasone; Colecalciferol; Potassium Acetate; Magnesium Sulfate; Verapamil; Diclofenac Sodium; Methotrexate; Pantoprazole; Metoclopramide; Metoprolol Tartrate; Acetaminophen; Enoxaparin



Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-06-18

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Pruritus, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda
    Dosage: 1200mg per day
    Administration route: Oral
    Start date: 2011-09-12
    End date: 2011-11-13

Xeloda
    Dosage: 1200mg per day
    Administration route: Oral
    Start date: 2011-12-05
    End date: 2012-02-20

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-09-12
    End date: 2012-02-20

Xeloda
    Dosage: 900mg per day
    Administration route: Oral
    Start date: 2011-11-14
    End date: 2011-12-04

Other drugs received by patient: Crestor; Amlodipine



Possible Xeloda side effects in male

Reported by a physician from Japan on 2012-06-18

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Anorectal Disorder, Quadriplegia, Bladder Disorder, Multiple Sclerosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Oxaliplatin



Possible Xeloda side effects in male

Reported by a physician from Australia on 2012-06-13

Patient: male, weighing 93.0 kg (204.6 pounds)

Reactions: Cerebral Infarction, Hemiplegia

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Gliclazide; Metformin HCL; Panadol Osteo; Lipitor; Irinotecan HCL



Possible Xeloda side effects in male

Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-06-12

Patient: male

Reactions: Blindness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in 34 year old male

Reported by a physician from China on 2012-06-12

Patient: 34 year old male, weighing 55.0 kg (121.0 pounds)

Reactions: Neck Pain, Deafness, Condition Aggravated, Headache, Blindness, Metastases To Central Nervous System

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Celebrex
    Administration route: Oral
    Start date: 2011-12-30
    End date: 2011-12-31

Eloxatin
    Start date: 2011-12-01
    End date: 2011-12-01

Eloxatin
    Start date: 2011-09-02
    End date: 2011-09-02

Xeloda
    Dosage: from day 1 to day 14.
    Administration route: Oral
    Start date: 2011-09-02
    End date: 2011-12-01



Possible Xeloda side effects in male

Reported by a physician from Japan on 2012-06-06

Patient: male, weighing 55.0 kg (121.0 pounds)

Reactions: Interstitial Lung Disease, Pneumomediastinum, Subcutaneous Emphysema

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Prednisolone
    Administration route: Oral
    Indication: Interstitial Lung Disease
    Start date: 2012-02-07
    End date: 2012-02-23

Avastin
    Indication: Rectal Cancer Metastatic
    Start date: 2011-07-15
    End date: 2011-12-01

Xeloda
    Dosage: the seventh administering/ on the 14th
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    Start date: 2011-07-15
    End date: 2012-01-20

Prednisolone
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-03-07

Methylprednisolone Sodium Succinate
    Indication: Interstitial Lung Disease
    Start date: 2012-02-04
    End date: 2012-02-06

Prednisolone
    Administration route: Oral
    Start date: 2012-03-08

Oxaliplatin
    Indication: Rectal Cancer Metastatic
    Start date: 2011-07-15
    End date: 2012-01-01

Other drugs received by patient: Glufast; Metformin Hydrochloride; Warfarin Sodium; Losartan Potassium; Halfdigoxin KY; Nizatidine



Possible Xeloda side effects in female

Reported by a individual with unspecified qualification from Japan on 2012-05-23

Patient: female

Reactions: Uterine Cancer, Urinary Tract Infection, Anaemia, Meningitis Bacterial, Leukoencephalopathy, Liver Disorder

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2007-08-01
    End date: 2010-12-12

Cefpirome Sulfate
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-12-13
    End date: 2010-12-20

Cyclophosphamide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-02-01
    End date: 2010-12-12

Cefpirome Sulfate
    Administration route: Oral
    End date: 2010-12-12

Other drugs received by patient: Mucosta; Tocopherol Concentrate CAP; Celestamine TAB; Meloxicam; Hirudoid; Cyclophosphamide; Neurovitan (Ukraine); Atines



Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-22

Patient: female

Reactions: Anxiety, Diarrhoea, Dizziness, Palmar-Plantar Erythrodysaesthesia Syndrome, Gait Disturbance, Suicidal Ideation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Effexor XR
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Keppra
    Indication: Product Used FOR Unknown Indication

Ativan
    Indication: Product Used FOR Unknown Indication

Keppra

Other drugs received by patient: Herceptin



Possible Xeloda side effects in 56 year old female

Reported by a consumer/non-health professional from Canada on 2012-05-15

Patient: 56 year old female

Reactions: Vomiting Projectile, Pain in Extremity, Quality of Life Decreased, Rhinorrhoea, Balance Disorder, Visual Impairment, Gait Disturbance, Ophthalmological Examination Abnormal, Blindness, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in female

Reported by a physician from Finland on 2012-05-09

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Gastrointestinal Mucosal Exfoliation, Neutropenic Sepsis, Enterobacter Sepsis, Encephalopathy, Pyrexia, Ketoacidosis, Diarrhoea, Thrombocytopenia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Docetaxel; Insulin



Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-05-03

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Pneumonia Bacterial

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda
    Dosage: 3000mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-04-23
    End date: 2011-05-30

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Start date: 2011-06-25
    End date: 2011-12-16

Xeloda
    Dosage: 3000mg per day
    Administration route: Oral
    Start date: 2011-06-25
    End date: 2011-12-16

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-04-23

Tykerb
    Administration route: Oral
    Start date: 2011-05-14

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    End date: 2011-05-30

Other drugs received by patient: Pydoxal



Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-05-02

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Pruritus, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda
    Dosage: 1200mg per day
    Administration route: Oral
    Start date: 2011-12-05
    End date: 2012-02-20

Xeloda
    Dosage: 1200mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-12
    End date: 2011-11-13

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-09-12
    End date: 2012-02-20

Xeloda
    Dosage: 900mg per day
    Administration route: Oral
    Start date: 2011-11-14
    End date: 2011-12-04

Other drugs received by patient: Amlodipine; Crestor



Possible Xeloda side effects in male

Reported by a physician from Japan on 2012-04-30

Patient: male

Reactions: Cerebral Infarction

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Large Intestine Carcinoma
    Start date: 2012-01-01

Avastin
    Dosage: dosage is uncertain.
    Indication: Colorectal Cancer
    Start date: 2011-12-10
    End date: 2011-12-10

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Colorectal Cancer
    End date: 2011-12-01

Other drugs received by patient: Oxaliplatin



Possible Xeloda side effects in male

Reported by a physician from Belgium on 2012-04-27

Patient: male, weighing 63.3 kg (139.3 pounds)

Reactions: Anaemia, International Normalised Ratio Increased, Colitis, Hypokalaemia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Avastin
    Indication: Rectal Cancer

Xeloda
    Indication: Rectal Cancer

Oxaliplatin
    Indication: Colon Cancer
    Start date: 2012-02-13

Xeloda
    Administration route: Oral
    Indication: Colon Cancer
    Start date: 2012-02-13

Avastin
    Indication: Colon Cancer
    Start date: 2012-02-13

Oxaliplatin
    Indication: Rectal Cancer



Possible Xeloda side effects in male

Reported by a physician from Japan on 2012-04-20

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Jaundice, Bile Duct Stenosis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Irinotecan Hydrochloride
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent

Xeloda
    Administration route: Oral
    Indication: Rectal Cancer Recurrent
    Start date: 2009-12-15
    End date: 2010-10-13

Oxaliplatin
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent
    Start date: 2009-12-15

Erbitux
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent

Other drugs received by patient: Novorapid; Lantus; Pydoxal



Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-20

Patient: female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Taxotere
    Start date: 2010-03-26
    End date: 2010-07-16

Femara
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2008-04-01
    End date: 2010-08-01

Doxorubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2011-03-11
    End date: 2011-07-01

Taxotere
    Indication: Breast Cancer
    Start date: 2006-11-17
    End date: 2007-01-05

Aromasin
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-08-01
    End date: 2010-11-01

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-26
    End date: 2011-01-26

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-11-01
    End date: 2011-01-01

Fluorouracil
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Tamoxifen Citrate
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-06-01
    End date: 2008-04-01



Possible Xeloda side effects in male

Reported by a individual with unspecified qualification from Mexico on 2012-04-18

Patient: male

Reactions: Neurotoxicity, Palmar-Plantar Erythrodysaesthesia Syndrome, Blindness

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral

Xeloda
    Administration route: Oral

Xeloda
    Administration route: Oral
    Indication: Gastrointestinal Cancer Metastatic
    Start date: 2011-03-01

Xeloda
    Administration route: Oral



Possible Xeloda side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-17

Patient: 43 year old female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: unk
    Start date: 2011-03-11
    End date: 2011-07-01

Tamoxifen Citrate
    Dosage: unk
    Administration route: Oral
    Start date: 2007-06-01
    End date: 2008-04-01

Aromasin
    Dosage: unk
    Administration route: Oral
    Start date: 2010-08-01
    End date: 2010-11-01

Taxotere
    Dosage: unk
    Start date: 2006-11-17
    End date: 2007-01-05

Avastin
    Dosage: unk
    Start date: 2010-08-01
    End date: 2010-11-01

Epirubicin Hydrochloride
    Dosage: 100 mg, unk
    Start date: 2006-09-15
    End date: 2006-10-27

Femara
    Dosage: unk
    Administration route: Oral
    Start date: 2008-04-01
    End date: 2010-08-01

Cyclophosphamide
    Dosage: 500 mg, unk
    Start date: 2006-09-15
    End date: 2006-10-27

Avastin
    Dosage: unk
    Start date: 2010-11-01
    End date: 2011-01-26

Fluorouracil
    Dosage: 500 mg, unk
    Start date: 2006-09-15
    End date: 2006-10-27

Avastin
    Dosage: unk
    Start date: 2010-03-26
    End date: 2010-07-16

Xeloda
    Dosage: unk
    Administration route: Oral
    Start date: 2010-11-01
    End date: 2011-01-01

Taxotere
    Dosage: unk
    Start date: 2010-03-26
    End date: 2010-07-16



Possible Xeloda side effects in female

Reported by a physician from France on 2012-04-13

Patient: female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Fluorouracil
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-15
    End date: 2006-10-27

Tamoxifen Citrate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-06-01
    End date: 2008-04-01

Femara
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-04-01
    End date: 2010-08-01

Xeloda
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-11-01
    End date: 2011-01-01

Cyclophosphamide
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-15
    End date: 2006-10-27

Doxorubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-11
    End date: 2011-07-01

Aromasin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-11-01

Avastin
    Start date: 2010-08-01
    End date: 2010-11-01

Avastin
    Start date: 2010-11-01
    End date: 2011-01-26

Avastin
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-26
    End date: 2010-07-01

Epirubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-15
    End date: 2006-10-27

Taxotere
    Dosage: 6 cycles
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-11-17
    End date: 2007-01-05

Taxotere
    Dosage: 6 cycles
    Start date: 2010-03-26
    End date: 2010-07-16



Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-12

Patient: female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2011-03-11
    End date: 2011-07-01

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Aromasin
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-08-01
    End date: 2010-11-01

Taxotere
    Start date: 2010-03-26
    End date: 2010-07-16

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-26
    End date: 2011-01-26

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-11-01
    End date: 2011-01-01

Taxotere
    Indication: Breast Cancer
    Start date: 2006-11-17
    End date: 2007-01-05

Tamoxifen Citrate
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-06-01
    End date: 2008-04-01

Femara
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2008-04-01
    End date: 2010-08-01

Fluorouracil
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012